Zimmer Biomet Unveils Latest Enhancements to ZBEdge™ Dynamic Intelligence™ at AAOS 2023 Annual Meeting

New updates for mymobility® Digital care management platform, ROSA® Knees and Persona IQ® The Smart Knee® will be presented alongside a comprehensive portfolio of orthopedic solutions

WARSAW, Indiana, March 7, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a leading global medical technology company, today announced plans to present the latest enhancements to ZBEdge™ Dynamic Intelligence™ at the 2023 American Academy of Orthopedic Surgeon (AAOS) Annual Meeting in Las Vegas. ZBEdge Dynamic Intelligence integrates Zimmer Biomet’s digital, robotic and implant technologies, connecting and collecting objective data throughout the caregiver. ZBEdge is able to turn data into insights to empower healthcare providers and raise the standard of care. During the meeting, taking place March 7-11, the company will announce updates to the mymobility® digital care management platform, ROSA® Knees and Persona IQ® The Smart Knee®while also highlighting the HipInsight™ Mixed Reality System* on the OptiVu™ platform and the intelligent operating room of the Omni™ suite.

(PRNews photo/Zimmer Biomet Holdings, Inc.)

“Nearly two years after its launch, ZBEdge Dynamic Intelligence continues to innovate with breakthrough technologies that enable smarter decision making, more efficient care and optimized user experiences,” said Ivan Tornos, chief operating officer at Zimmer Biomet. “AAOS has always been a leading event to introduce the orthopedic community to the latest developments in our ZBEdge portfolio, which harness the power of robotics, artificial intelligence, mixed reality and predictive data analytics to help surgeons improve patient outcomes.”

Key ZBEdge enhancements unveiled at the 2023 AAOS Annual Meeting include:

  • mymobility: a digital care management platform that provides patient support and guidance, and collects ongoing data and patient-reported feedback to facilitate care, outcomes, and patient satisfaction with surgical preparation and recovery.
    • WalkAI™ integration Recovery curves to help surgeons track their patients’ recovery by comparing patients’ gait scores to a matched cohort and providing predictions of their 90-day gait speed.
    • WalkAI Patient Progress integration to help patients track and focus on their recovery via the smartphone app and see how their predicted walking speed recovery compares to their peers 90 days post-surgery.
    • Clinician Mobile Experience integration to enable healthcare providers to manage and track patients on the go, enable faster enrollment and get a better user experience.
  • Persona IQ: the world’s first and only smart knee implant that enables physicians and care teams to collect patient-specific kinematic data, including functional knee range of motion, qualified step count, distance walked, cadence, stride length and sampled average walking speed, accessible remotely are mymobility platform.
    • Canary Quantiles™ integration§ Recovery curves to provide surgeons with cohort-comparative postoperative gait parameters over the course of patient monitoring and postoperative care.
  • PINK knees: a robotic surgical system that uses real-time insights to help surgeons optimize outcomes when performing knee replacement surgeries.
    • Software and hardware improvements, including improvements to optimized landmarks, knee condition assessment, slice validation, and data.
    • Compatibility with Personas® OsseoTi® Keel Tibia for cementless knee replacement.
    • Integration of Enhanced Mixed Reality to optimize intraoperative interaction with the ROSA Knee platform.

The Zimmer Biomet booth (#2543) at the 2023 AAOS Annual Meeting will feature demonstrations of the company’s orthopedic solutions and ZBEdge Dynamic Intelligence. For more information on Zimmer Biomet events at AAOS 2023, visit www.zimmerbiomet.com/en/academy2023.html.

About Zimmer Biomet
Zimmer Biomet is a global leader in medical technology with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and a range of integrated digital and robotic technologies leveraging data, data analytics and artificial intelligence.

With more than 90 years of trusted leadership and proven expertise, Zimmer Biomet is able to deliver the highest quality solutions to patients and providers. Our legacy lives on today through our progressive culture of evolution and innovation.

For more information about our product portfolio, operations in 25+ countries and sales in 100+ countries, or to join our team, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding Zimmer Biomet’s expectations, plans, prospects and products and service offerings, including new product launches and potential clinical achievements . Such statements are based on management’s current beliefs and expectations and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially. A list and description of some of these risks and uncertainties can be found in Zimmer Biomet’s periodic reports filed with the US Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements contained in Zimmer Biomet’s filings with the SEC. Forward-looking statements speak only as of the date on which they are made, and Zimmer Biomet disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Readers of this press release are cautioned not to place undue reliance on these forward-looking statements, as there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement applies to all forward-looking statements contained in this press release.

* HipInsight System is a trademark of Surgical Planning Associates, Inc.

WalkAI is available to hip and knee replacement patients using mymobility on a compatible smartphone.

Warning – The kinematic data from this device has no clinical utility. It is not intended to be used for clinical decision making and no data has been evaluated by the FDA for clinical utility.

§ Canary Quantiles™ Recovery Curves software provides healthcare professionals (HCPs) with additional aggregated population data when managing a patient’s postoperative care following a total knee arthroplasty (TKA). HCPs can filter or select options for additional views based on patient demographics (eg, age) to analyze trends and outcomes. With Canary Quantiles Recovery Curves software, HCPs can view aggregated patient population data to analyze patient recovery progress and direction of outcome.

The Canary Quantiles Recovery Curves software does not control the function or parameters of the Canturio™ Tibia Extension (CTE) with Canary Health Implanted Reporting Processor (CHIRP®) system and is not intended for active patient monitoring.

The CTE with CHIRP system is intended to provide objective kinematic data of the implanted medical device during the postoperative care of a patient after total knee arthroplasty (TKA). The kinematic data is a complement to other tools for measuring physiological parameters applied or used by the physician in the course of patient monitoring and treatment after surgery.

The device is indicated for use in patients undergoing a cemented TKA procedure, typically indicated for a minimum 58mm tibial stem lengthening.

The objective kinematic data generated by CTE using the CHIRP system is not intended to support clinical decision making and no clinical benefit has been demonstrated.

The CTE with CHIRP system is compatible with Zimmer Biomet Persona® The personalized knee® System.

Decision View original content to download multimedia: https://www.prnewswire.com/news-releases/zimmer-biomet-unveils-latest-enhancements-to-zbedge-dynamic-intelligence-at-aaos-2023-annual -meeting-301763972.html

SOURCE Zimmer Biomet Holdings, Inc.

Company codes: Swiss:ZBH, NYSE:ZBH


Leave a Reply

Your email address will not be published. Required fields are marked *